Latest Hypolipidemic agent Stories
By MARIA CHENG By Maria Cheng The Associated Press MUNICH, Germany Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday.
By Alex Berenson When the U.S. Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical trials covering a total of 3,900 patients.
By Steve Sternberg The editors of a leading medical journal cautioned Tuesday that, without more data, it's impossible to rule out a link between the cholesterol-lowering drug Vytorin and cancer.
An editorial in the New England Journal of Medicine says more study is needed of the cholesterol-lowering drugs Zetia and Vytorin.
By Steve Sternberg A study that unexpectedly linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists worried that the drug's risks may outweigh its benefits.
By ALICIA CHANG, THE ASSOCIATED PRESS Scientists may have found a way to test for and possibly avoid the most serious side effect of cholesterol-lowering statin drugs, one of the top-selling medicines in the world. In rare cases, statins can cause muscle pain and weakness.
By JANJARVIS FORT WORTH, Texas - Beverly Morgan of Arlington, Texas, was 16 when she started taking the popular cholesterol-lowering drug Vytorin. But she eventually abandoned the medication.
By Jan Jarvis FORT WORTH, Texas - Beverly Morgan of Arlington, Texas, was 16 when she started taking the popular cholesterol-lowering drug Vytorin. However, she eventually abandoned the medication.
The American Academy of Pediatrics (AAP) released new guidelines on July 7, 2008, recommending that some children as young as 8 years old be given cholesterol-fighting drugs to ward off future heart problems. It is the strongest guidance ever given by the AAP.
My daughter Kaitlyn is 8 years old. According to the American Academy of Pediatrics, she's ready for cholesterol-lowering drugs. Yes, you read that right.